Malaria Prophylaxis for Kenya
For a non-pregnant adult traveler to Kenya without contraindications, mefloquine is the recommended first-line malaria prophylaxis regimen, given Kenya's high risk of chloroquine-resistant Plasmodium falciparum malaria. 1
Why Mefloquine for Kenya
Kenya is specifically highlighted in the guidelines as a high-risk area where deaths from malaria in British travelers commonly occur 1. The evidence is clear:
- Mefloquine demonstrates 91% prophylactic effectiveness in East Africa, significantly superior to chloroquine plus proguanil (72% effectiveness) and far better than chloroquine alone (10-42% effectiveness) 2
- Kenya has widespread chloroquine-resistant falciparum malaria, making chloroquine-based regimens inadequate 1, 3
- The guidelines explicitly state that for sub-Saharan Africa, including Kenya, mefloquine is recommended due to high risk and common chloroquine resistance 1
Dosing Regimen
- 250 mg weekly (adult dose)
- Start 1 week before travel to establish habit and assess tolerance 1, 4
- Continue weekly during travel
- Continue for 4 weeks after leaving the malarious area 1
Alternative Options
If mefloquine is not tolerated or acceptable:
Doxycycline (100 mg daily):
- Effective alternative for short-term travelers 4
- Start 1-2 days before travel
- Continue daily during travel and for 4 weeks after departure
- Caution: Photosensitivity risk—avoid prolonged sun exposure, use UVA-blocking sunscreen, take in evening 4
Atovaquone-proguanil (newer option):
- Highly efficacious (100% protection in Kenya studies) 5
- Well-tolerated with side effect profile similar to placebo
- Though not mentioned in the older guidelines, this represents a modern alternative
Critical Caveats
Mefloquine contraindications to screen for 4:
- History of seizures, epilepsy, or psychiatric disorder
- Concurrent use of beta blockers or cardiac conduction-altering drugs
- Tasks requiring fine motor coordination (pilots)
- Liver impairment
Neuropsychiatric effects: Occur in 0.01% (severe) but British experience suggests higher frequency. These typically manifest in the first three doses (70% of cases) and include anxiety, depression, sleep disturbances, nightmares, and rarely hallucinations or psychotic episodes 1, 4. Despite this, the frequency remains low enough to recommend mefloquine for high-risk chloroquine-resistant areas like Kenya.
Essential Non-Drug Measures
Chemoprophylaxis provides substantial but not 100% protection—breakthroughs occur on all regimens 1. Therefore:
- Use permethrin-impregnated bed nets
- Wear long sleeves and trousers after sunset
- Apply DEET-containing repellents to exposed skin
- Sleep in screened rooms; use knockdown insecticides
Post-Travel Vigilance
Any fever or flu-like illness within one year of returning from Kenya requires emergency investigation for malaria 1. Most deaths occur in those who don't comply fully with prophylaxis or who delay seeking care for fever.
The combination of mefloquine's superior efficacy (91% vs 72% for alternatives) 2, Kenya's specific high-risk status with documented traveler deaths 1, and the prevalence of chloroquine resistance 3 makes mefloquine the evidence-based first choice for this scenario.